Kinase Inhibitor is Highly Active in MET-amplified Gastric Cancer

June 2017

Research

Country of origin: USA

An investigational kinase inhibitor that blocks the MET signaling pathway is highly active and well tolerated in patients with gastric and related cancers that have amplification of the MET gene, according to a trial reported at the annual Gastrointestinal Cancers Symposium sponsored by the American Society of Clinical Oncology.

Nearly two-thirds of such patients in the open-label phase 1 trial had a response to AMG 337, an oral, potent, and highly selective inhibitor of c-Met, reported lead investigator Dr. Eunice L. Kwak, a medical oncologist at the Massachusetts General Hospital, Boston.

“Dramatic responses to AMG 337 were observed in a subset of patients with MET-amplified esophagogastric cancers. This demonstrates that MET amplification is an oncogenic driver in some of these cancers,” she contended.

Resources

The Linus Pauling Institute February 2018 The Linus Pauling Institute at Oregon State University has a website intended to provide ?scientific information on health...
My PearlPoint Cancer Side Effects January 2018 My PearlPoint Cancer Side Effects app provides nutrition guidance from oncology RDs, education articles, clinical trial...
myCME, continuing medical education January 2018 myCME, the fastest growing online source of continuing medical education for healthcare professionals, is available in a...
Clinical Trial Seek app January 2018 Clinical Trial Seek app is a NIH database of cancer clinical trials. One can search clinical trials in their geographic...
Endocrinology Advisor January 2018 Endocrinology Advisor is a free, simple to use, medical app that offers endocrinologists, diabetes educators and other...
Renal & Urology News (RUN) January 2018 Renal & Urology News (RUN) is the only medical tabloid for both practicing kidney specialists and urologists. With the RUN...
Neurology Advisor app January 2018 Neurology Advisor is a free, simple to use, medical app that offers neurologic healthcare professionals a comprehensive...
The Drugs & Bugs app January 2018 The Drugs & Bugs app by Monthly Prescribing Reference (MPR) is an essential resource for allied healthcare professionals,...
inPractice® Oncology January 2018 inPractice® Oncology is the only point-of-care clinical reference designed to meet the unique needs of specialists. Full...
Reducing the Inappropriate Use of Antibiotics December 2017 The National Public Health Service for Wales (NPHS) has published its second annual report from its Antimicrobial...
Search by Keyword